Patients

Views & Analysis

‘No going back’ for clinical trials after COVID

Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result.

Views & Analysis

How patient insights are changing trial solutions

Patients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening.

Views & Analysis

True patient-focused research through decentralised and hybr...

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?

Views & Analysis

Boosting the impact of patient services

New research from Accenture has revealed that adoption of patient support services hasn’t improved since 2015 despite increasing pharma investment.

Views & Analysis

COVID-19 – Delivering a pandemic of change to digital medica...

As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving to digital solutions.

Views & Analysis

Finding agility in unprecedented times

Nicole Farmer, general manager, UK & Ireland at Sanofi Genzyme, tells us how the company aimed for agile adaptation during COVID-19, and how these lessons are driving patient centricity

‘No going back’ for clinical trials after COVID

How patient insights are changing trial solutions

True patient-focused research through decentralised and hybr...

Boosting the impact of patient services

COVID-19 – Delivering a pandemic of change to digital medica...

Finding agility in unprecedented times

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Patients

Editor's Picks